Herriot Tabuteau
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $103M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 7SEC | AXSMAxsome Therapeutics, Inc. | Sell Plan | 45,0047,229 held (−86%) | $212.01 | $9.5M | -20.6% |
| Aug 7SEC | AXSMAxsome Therapeutics, Inc. | Sell Plan | 4,6607,229 held (−39%) | $213.95 | $997K | -21.3% |
| Jul 1SEC | AXSMAxsome Therapeutics, Inc. | Sell Plan | 49,6667,229 held (−87%) | $240.25 | $11.9M | -29.9% |
| Jun 9SEC | AXSMAxsome Therapeutics, Inc. | Sell Plan | 49,6707,229 held (−87%) | $241.01 | $12.0M | -30.1% |
| Feb 2SEC | AXSMAxsome Therapeutics, Inc. | Sell Plan | 32,4107,229 held (−82%) | $185.60 | $6.0M | -9.3% |
| Jan 7SEC | AXSMAxsome Therapeutics, Inc. | Sell Plan | 78,7037,229 held (−92%) | $171.28 | $13.5M | -1.7% |
| Jan 7SEC | AXSMAxsome Therapeutics, Inc. | Sell Plan | 29,4507,229 held (−80%) | $172.33 | $5.1M | -2.3% |
| Jan 7SEC | AXSMAxsome Therapeutics, Inc. | Sell Plan | 31,2617,229 held (−81%) | $170.38 | $5.3M | -1.2% |
| Dec 4SEC | AXSMAxsome Therapeutics, Inc. | Sell Plan | 49,2527,229 held (−87%) | $144.59 | $7.1M | +16.4% |
| Dec 4SEC | AXSMAxsome Therapeutics, Inc. | Sell Plan | 20,1637,229 held (−74%) | $146.94 | $3.0M | +14.6% |
| Dec 4SEC | AXSMAxsome Therapeutics, Inc. | Sell Plan | 10,5587,229 held (−59%) | $148.18 | $1.6M | +13.6% |
| Nov 5SEC | AXSMAxsome Therapeutics, Inc. | Sell Plan | 91,7057,229 held (−93%) | $132.34 | $12.1M | +27.2% |
| Nov 5SEC | AXSMAxsome Therapeutics, Inc. | Sell Plan | 50,4597,229 held (−87%) | $133.79 | $6.8M | +25.8% |
| Nov 5SEC | AXSMAxsome Therapeutics, Inc. | Sell Plan | 21,7757,229 held (−75%) | $134.49 | $2.9M | +25.2% |
| Oct 8SEC | AXSMAxsome Therapeutics, Inc. | Sell Plan | 19,2207,229 held (−73%) | $120.17 | $2.3M | +40.1% |
| Oct 8SEC | AXSMAxsome Therapeutics, Inc. | Sell Plan | 13,3907,229 held (−65%) | $118.77 | $1.6M | +41.7% |
| Oct 8SEC | AXSMAxsome Therapeutics, Inc. | Sell Plan | 12,7747,229 held (−64%) | $118.84 | $1.5M | +41.7% |
- Sell
CEO Herriot Tabuteau sold $9.5M of AXSM at $212.01 — cuts the stake by 86%; pre-scheduled 10b5-1 plan sale.
- Sell
CEO Herriot Tabuteau sold $997K of AXSM at $213.95 — cuts the stake by 39%; pre-scheduled 10b5-1 plan sale.
- Sell
CEO Herriot Tabuteau sold $11.9M of AXSM at $240.25 — cuts the stake by 87%; pre-scheduled 10b5-1 plan sale.
- Sell
CEO Herriot Tabuteau sold $12.0M of AXSM at $241.01 — cuts the stake by 87%; pre-scheduled 10b5-1 plan sale.
- Sell
CEO Herriot Tabuteau sold $6.0M of AXSM at $185.60 — cuts the stake by 82%; pre-scheduled 10b5-1 plan sale.
- Sell
CEO Herriot Tabuteau sold $13.5M of AXSM at $171.28 — cuts the stake by 92%; pre-scheduled 10b5-1 plan sale.